Otsuka (OTCMKTS:OTSKY) Announces Earnings Results, Beats Estimates By $0.19 EPS

Otsuka (OTCMKTS:OTSKY) released its quarterly earnings results on Friday. The company reported $0.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19, Zacks reports. Otsuka had a net margin of 15.01% and a return on equity of 12.33%. Otsuka updated its FY 2026 guidance to 2.119-2.119 EPS.

Otsuka Stock Down 4.0%

Shares of OTSKY traded down $1.42 on Friday, reaching $34.41. The stock had a trading volume of 50,665 shares, compared to its average volume of 39,974. The firm has a market capitalization of $36.96 billion and a price-to-earnings ratio of 14.52. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17. The company has a 50-day simple moving average of $34.19 and a 200-day simple moving average of $33.51. Otsuka has a 12-month low of $23.67 and a 12-month high of $37.52.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.